RE: Sale28 May 2019 10:04
I think it's a terrible deal. £1.75 million in cash, most of which is deferred. The RNS says the 25 million shares represents 33% of ValOre but this will be diluted very substantial as ValOre have to do a large placing to buy the asset and take it forward. Perhaps JAN will end up with 15 to 20%.
The vanadium asset JAN is left with looks promising but it is very early stage and Vanadium prices have been declining.